drug

ELI-002 2P

Phase 2updated 3mo ago

by $ELTX Elicio Therapeutics, Inc.

Phase 2

community read0 votes

indications

Colorectal Cancer

all catalysts(0)

nothing on the calendar yet

Trials studying ELI-002 2P

phase1A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumorscompletedn=25

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 4m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

ELI-002 2P

Phase 2updated 3mo ago

by $ELTX Elicio Therapeutics, Inc.

Phase 2

community read0 votes

indications

Colorectal Cancer

all catalysts(0)

nothing on the calendar yet

Trials studying ELI-002 2P

phase1A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumorscompletedn=25

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 4m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

ELI-002 2P

indications

all catalysts(0)

Trials studying ELI-002 2P

News(0)

Report a data issue

comments(0)

ELI-002 2P

indications

all catalysts(0)

Trials studying ELI-002 2P

News(0)

Report a data issue

comments(0)